Abstract

The dehydrogenative alkenylation of C-H bonds with alkenes represents an atom- and step-economical approach for olefin synthesis and molecular editing. Site-selective alkenylation of alkanes and aldehydes with the C-H substrate as the limiting reagent holds significant synthetic value. We herein report a photocatalytic method for the direct alkenylation of alkanes and aldehydes with aryl alkenes in the absence of any external oxidant. A diverse range of commodity feedstocks and pharmaceutical compounds are smoothly alkenylated in useful yields with the C-H partner as the limiting reagent. The late-stage alkenylation of complex molecules occurs with high levels of site selectivity for sterically accessible and electron-rich C-H bonds. This strategy relies on the synergistic combination of direct hydrogen atom transfer photocatalysis with cobaloxime-mediated hydrogen-evolution cross-coupling, which promises to inspire additional perspectives for selective C-H functionalizations in a green manner.

Highlights

  • The dehydrogenative alkenylation of C-H bonds with alkenes represents an atom- and stepeconomical approach for olefin synthesis and molecular editing

  • We were inspired by direct hydrogen atom transfer (HAT) photocatalysts that could achieve the straightforward activation of C–H bonds[33]

  • We proposed that the combination of decatungstate anion and a cobaloxime catalyst could enable the direct activation and alkenylation of alkanes and aldehydes using alkenes as the feedstocks

Read more

Summary

Introduction

The dehydrogenative alkenylation of C-H bonds with alkenes represents an atom- and stepeconomical approach for olefin synthesis and molecular editing. In pursuing methods for olefin construction[25,26,27] and photomediated C–H bond functionalization[28,29,30,31], we aspired to develop an auxiliary-free and oxidant-free strategy for Csp3–H and Csp2(O)–H alkenylation with the C–H substrate as the limiting reagent (Fig. 1c). This would allow the late-stage functionalization of advanced synthetic intermediates and pharmaceutical relevant molecules without de novo synthesis[32]. Of particular interest was the a Auxiliary-assisted alkenylation: DG

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call